Mersana Therapeutics, Inc. ( MRSN) - Key Metrics
Stock symbol MRSN is outdated, potentially delisted? Maybe it is available on other exchange?
MRSN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.61 | -$4.87 | -$4.53 | -$4.53 |
| 2025Q1 | $0.55 | -$4.85 | -$5.89 | -$5.89 |
| 2024Q4 | $3.31 | -$2.86 | -$3.90 | -$3.90 |
| 2024Q3 | $2.57 | -$2.34 | -$1.75 | -$1.75 |
MRSN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -0.38 |
| 2025Q1 | ? | -0.44 |
| 2024Q4 | ? | -3.13 |
| 2024Q3 | ? | -5.04 |
MRSN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | ? | ? |
| 2025Q2 | -61.25% | ? |
| 2025Q1 | -68.49% | ? |
| 2024Q4 | -10.90% | ? |
| 2024Q3 | -3.70% | ? |
MRSN
Price: $29.08
52 week price:
Earnings Per Share: -13.95 USD
P/E Ratio: -2.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 915100
Ebitda: -7.8 millionMarket Capitalization: 147.0 million